Sarepta Therapeutics (SRPT) Restructuring Costs (2020 - 2025)
Sarepta Therapeutics' (SRPT) quarterly Restructuring Costs came in at $1.5 million in Q4 2025, down 96.3% quarter-over-quarter from $40.5 million in Q3 2025.
Sarepta Therapeutics (SRPT) Restructuring Costs (2020 - 2025) Analysis & Trends
Sarepta Therapeutics' Restructuring Costs history runs 2 years deep, the most recent figure standing at $1.5 million for Q4 2025.
- On a quarterly basis, Restructuring Costs changed N/A year-over-year to $1.5 million in Q4 2025; TTM through Dec 2025 was $42.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $42.0 million, changed N/A from the prior year.
- Restructuring Costs eased to $1.5 million in Q4 2025 per SRPT's latest filing, from $40.5 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $40.5 million in Q3 2025 and bottomed at $1.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Sarepta Therapeutics | 1.66 Bn | 1.25 Bn | 622.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 40.50 Mn |
| Sep 30, 2020 | 45.00 Mn |